Karin Karlsson

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

Jeff P. Sharman, Miklós Egyed, Wojciech Jurczak et al. · The Lancet · 2020 · 612 citations · Full text

Medicine, Hematology, Pharmacology +10

Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis

Fiona Murray, Nikos Darzentas, Anastasia Hadzidimitriou et al. · Blood · 2007 · 330 citations · Full text

Life Sciences, Hematology, Immunology +13

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vλ2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

Gerard Tobin, Ulf Thunberg, Anna Johnson et al. · Blood · 2003 · 310 citations

Life Sciences, Immunology, Molecular Biology +13

Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group.

Stefan Lohmander, Nils Dalén, M. Hämäläinen et al. · Annals of the Rheumatic Diseases · 1996 · 279 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status

Pawel Grabowski, Magnus Hultdin, Karin Karlsson et al. · Blood · 2005 · 116 citations · Full text

Medicine, Hematology, Oncology +17